SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

SunTrust Robinson Humphrey Initiates Coverage On Vertex Pharmaceuticals with Buy Rating, Announces $235 Price Target

SunTrust Robinson Humphrey initiates coverage on Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy rating and a $235 price target.

Benzinga · -

SunTrust Robinson Humphrey initiates coverage on Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy rating and a $235 price target.